参考文献/References:
[1] LI YC,ZHAO CH,YU ZB,et al.Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma[J].Oncotarget,2016,7(42):68585-68596.
[2] 郭会利,郭树农,王军辉,等.氯化锶注射液治疗转移性骨肿瘤的临床疗效观察[J].中医正骨,2014,26(1):70-71.
[3] BOUVIER C,MACAGNO N,NGUYEN Q,et al.Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and beta 1-integrin in conventional osteosarcoma[J].Oncotarget,2016,7(40):64702-64710.
[4] ANDERSON ME.Update on survival in osteosarcoma[J].Orthop Clin North Am,2016,47(1):283-292.
[5] LETTIERI CK,APPEL N,LABBAN N,et al.Progress and opportunities for immune therapeutics in osteosarcoma[J].Immunotherapy,2016,8(10):1233-1244.
[6] 刘小军.以异常能量代谢为靶点治疗恶性肿瘤的研究进展[J].复旦学报:医学版,2012,39(6):676-679.
[7] 菅记涌,张勇,朱大海.丙酮酸脱氢酶激酶的研究进展[J].基础医学与临床,2008,28(11):1212-1215.
[8] WAKABAYASHI H,SAITO J,TAKI J,et al.Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma:comparison with Tc-99m-MIBI scintigraphy[J].Skeletal Radiol,2016,45(1):87-95.
[9] MA Y,XU W,BAI R,et al.Volume-based predictive biomarkers of sequential FDG-PET/CT for sunitinib in cancer of unknown primary:identification of the best benefited patients[J].Eur J Nucl Med Mol Imaging,2016,44(2):199-205.
[10] 童晶涛.丙酮酸脱氢酶激酶-1在结肠癌中的表达及在细胞增殖和化疗中的作用[D].重庆:第三军医大学,2010.
[11] RICHARD SM,MARIGNAC VL.Sensitization to oxaliplatin in HCT116 and HT29 cell lines by metformin and ribavirin and differences in response to mitochondrial glutaminase inhibition[J].J Cancer Res Ther,2015,11(2):336-340.
[12] PARK SY,YOON JK,PARK KJ,et al.Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheralnon-small cell lung cancer[J].CancerImaging,2015:21.
[13] 朱明珍,茅国新,蒋华,等.二氯乙酸钠诱导肺腺癌细胞株A549凋亡的实验研究[J].现代医药卫生,2014,30(3):321-323.
[14] LIU Z,SUN Y,TAN S,et al.Nutrient deprivation-related OXPHOS/glycolysis interconversion via HIF-1α/C-MYC pathway in U251 cells[J].Tumour Biol,2016,37(5):6661-6671.
[15] PRIGIONE A,ROHWER N,HOFFMANN S,et al.HIF1α modulates cell fate reprogramming through early glycolytic shift and upregulation of PDK1-3 and PKM2[J].Stem Cells,2014,32(2):364-376.
相似文献/References:
[1]罗明星,刘丙根,罗文礼,等.保肢与截肢治疗后骨肉瘤患者肢体功能及生活质量的Meta分析[J].中医正骨,2017,29(07):41.
LUO Mingxing,LIU Binggen,LUO Wenli,et al.Comparison of limb salvage and amputation on limb function and life quality of patients with osteosarcoma:a meta analysis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(01):41.
[2]丁聚贤,谢兴文,许伟,等.中医药在骨肉瘤放化疗中的作用研究进展[J].中医正骨,2018,30(05):43.
[3]罗漫丽,黄满玉,李东升,等.多种血清肿瘤相关抗原自身抗体联合检测对骨肉瘤的诊断价值研究[J].中医正骨,2021,33(04):32.
LUO Manli,HUANG Manyu,LI Dongsheng,et al.A study of the clinical value of combined detection on serum autoantibodies against tumor-associated antigens in the diagnosis of osteosarcomas[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2021,33(01):32.